| 0 |
CENTRAL NERVOUS SYSTEM ABSCESS |
13 |
0.2889 |
| 1 |
ADENOVIRUS INTERSTITIAL NEPHRITIS |
14 |
0.2500 |
| 2 |
MALACOPLAKIA |
103 |
0.2249 |
| 3 |
CENTRAL NERVOUS SYSTEM LUPUS |
43 |
0.1928 |
| 4 |
BACILLARY ANGIOMATOSIS |
25 |
0.1838 |
| 5 |
DISSEMINATED NOCARDIOSIS |
24 |
0.1727 |
| 6 |
HEART FAILURE WITH PRESERVED EJECTION FRACTION |
49 |
0.1667 |
| 7 |
MALACOPLAKIA GASTROINTESTINAL |
16 |
0.1633 |
| 8 |
CEREBRAL NOCARDIOSIS |
37 |
0.1588 |
| 9 |
BODY MASS INDEX ABNORMAL |
38 |
0.1557 |
| 10 |
ANGIOSARCOMA METASTATIC |
17 |
0.1393 |
| 11 |
DISSEMINATED MUCORMYCOSIS |
52 |
0.1320 |
| 12 |
MONKEYPOX |
36 |
0.1304 |
| 13 |
DONOR SPECIFIC ANTIBODY PRESENT |
20 |
0.1299 |
| 14 |
APOPTOSIS |
40 |
0.1294 |
| 15 |
URINOMA |
20 |
0.1266 |
| 16 |
RHODOCOCCUS INFECTION |
21 |
0.1265 |
| 17 |
PULMONARY NOCARDIOSIS |
104 |
0.1262 |
| 18 |
AMAUROSIS FUGAX |
134 |
0.1244 |
| 19 |
PANCREAS TRANSPLANT REJECTION |
25 |
0.1244 |
| 20 |
POLYOMAVIRUS VIRAEMIA |
129 |
0.1215 |
| 21 |
CRYPTOCOCCAL CUTANEOUS INFECTION |
21 |
0.1154 |
| 22 |
HUMAN EHRLICHIOSIS |
24 |
0.1148 |
| 23 |
GASTROINTESTINAL MUCORMYCOSIS |
19 |
0.1138 |
| 24 |
DISSEMINATED CRYPTOCOCCOSIS |
86 |
0.1136 |
| 25 |
EPIDERMODYSPLASIA VERRUCIFORMIS |
19 |
0.1131 |
| 26 |
BLASTOMYCOSIS |
53 |
0.1091 |
| 27 |
RENAL-LIMITED THROMBOTIC MICROANGIOPATHY |
25 |
0.1087 |
| 28 |
TRICHODYSPLASIA SPINULOSA |
41 |
0.1076 |
| 29 |
ACANTHAMOEBA INFECTION |
20 |
0.1064 |
| 30 |
VIRAL LOAD |
18 |
0.1040 |
| 31 |
WEST NILE VIRAL INFECTION |
78 |
0.1040 |
| 32 |
DISSEMINATED STRONGYLOIDIASIS |
22 |
0.1005 |
| 33 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
234 |
0.0998 |
| 34 |
TRICHOPHYTOSIS |
20 |
0.0943 |
| 35 |
PHAEOHYPHOMYCOSIS |
45 |
0.0939 |
| 36 |
CHRONIC ALLOGRAFT NEPHROPATHY |
73 |
0.0932 |
| 37 |
RENAL TRANSPLANT FAILURE |
91 |
0.0921 |
| 38 |
HERPES SIMPLEX HEPATITIS |
22 |
0.0917 |
| 39 |
PARVOVIRUS B19 INFECTION |
80 |
0.0894 |
| 40 |
CAT SCRATCH DISEASE |
35 |
0.0871 |
| 41 |
ALTERNARIA INFECTION |
32 |
0.0860 |
| 42 |
DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION |
19 |
0.0860 |
| 43 |
DELAYED GRAFT FUNCTION |
61 |
0.0858 |
| 44 |
CYTOMEGALOVIRUS SYNDROME |
14 |
0.0848 |
| 45 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
189 |
0.0833 |
| 46 |
C3 GLOMERULOPATHY |
17 |
0.0821 |
| 47 |
EMPHYSEMATOUS PYELONEPHRITIS |
15 |
0.0820 |
| 48 |
HERPES SIMPLEX OESOPHAGITIS |
15 |
0.0806 |
| 49 |
CRYPTOCOCCOSIS |
129 |
0.0791 |
| 50 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
399 |
0.0783 |
| 51 |
SEROSITIS |
42 |
0.0759 |
| 52 |
KIDNEY TRANSPLANT REJECTION |
355 |
0.0739 |
| 53 |
RENAL GRAFT INFECTION |
17 |
0.0733 |
| 54 |
CYSTITIS VIRAL |
27 |
0.0705 |
| 55 |
DERMATOPHYTOSIS |
20 |
0.0704 |
| 56 |
PULMONARY MUCORMYCOSIS |
37 |
0.0701 |
| 57 |
CYTOMEGALOVIRUS OESOPHAGITIS |
25 |
0.0679 |
| 58 |
UREAPLASMA INFECTION |
27 |
0.0662 |
| 59 |
COMPLICATIONS OF TRANSPLANTED HEART |
14 |
0.0651 |
| 60 |
CYTOMEGALOVIRUS GASTROENTERITIS |
14 |
0.0648 |
| 61 |
CRYPTOSPORIDIOSIS INFECTION |
34 |
0.0648 |
| 62 |
SCEDOSPORIUM INFECTION |
45 |
0.0637 |
| 63 |
PNEUMONIA CRYPTOCOCCAL |
59 |
0.0624 |
| 64 |
NOCARDIOSIS |
155 |
0.0605 |
| 65 |
HEART TRANSPLANT REJECTION |
62 |
0.0597 |
| 66 |
TRANSPLANT DYSFUNCTION |
106 |
0.0594 |
| 67 |
AMERICAN TRYPANOSOMIASIS |
16 |
0.0593 |
| 68 |
TRANSPLANT REJECTION |
475 |
0.0592 |
| 69 |
HISTOPLASMOSIS DISSEMINATED |
93 |
0.0586 |
| 70 |
INFECTION REACTIVATION |
67 |
0.0585 |
| 71 |
ANAL SQUAMOUS CELL CARCINOMA |
18 |
0.0584 |
| 72 |
CYTOMEGALOVIRUS VIRAEMIA |
259 |
0.0582 |
| 73 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
13 |
0.0560 |
| 74 |
HEPATITIS E |
88 |
0.0557 |
| 75 |
COMPLICATIONS OF TRANSPLANTED LUNG |
17 |
0.0554 |
| 76 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
20 |
0.0549 |
| 77 |
BK VIRUS INFECTION |
183 |
0.0542 |
| 78 |
RENAL TUBULAR ATROPHY |
47 |
0.0533 |
| 79 |
EPSTEIN-BARR VIRAEMIA |
57 |
0.0514 |
| 80 |
JC VIRUS INFECTION |
81 |
0.0506 |
| 81 |
ANGIOSARCOMA |
23 |
0.0499 |
| 82 |
LUNG TRANSPLANT REJECTION |
32 |
0.0485 |
| 83 |
MICROSPORIDIA INFECTION |
17 |
0.0484 |
| 84 |
GRAFT VERSUS HOST DISEASE IN LUNG |
23 |
0.0481 |
| 85 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
159 |
0.0481 |
| 86 |
TRANSPLANTATION COMPLICATION |
20 |
0.0476 |
| 87 |
GRAFT VERSUS HOST DISEASE IN LIVER |
34 |
0.0475 |
| 88 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
76 |
0.0474 |
| 89 |
IMMUNOGLOBULIN G4 RELATED DISEASE |
15 |
0.0470 |
| 90 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
95 |
0.0446 |
| 91 |
MENINGITIS CRYPTOCOCCAL |
78 |
0.0446 |
| 92 |
LUPUS NEPHRITIS |
83 |
0.0443 |
| 93 |
VISCERAL LEISHMANIASIS |
32 |
0.0443 |
| 94 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA |
26 |
0.0440 |
| 95 |
KIDNEY FIBROSIS |
76 |
0.0438 |
| 96 |
HUMAN POLYOMAVIRUS INFECTION |
23 |
0.0433 |
| 97 |
STRONGYLOIDIASIS |
70 |
0.0433 |
| 98 |
HUMAN HERPESVIRUS 6 INFECTION REACTIVATION |
15 |
0.0427 |
| 99 |
MUCORMYCOSIS |
109 |
0.0419 |
| 100 |
GRAFT VERSUS HOST DISEASE IN SKIN |
92 |
0.0417 |
| 101 |
GRAFT LOSS |
30 |
0.0414 |
| 102 |
PANCREATITIS HAEMORRHAGIC |
19 |
0.0409 |
| 103 |
CYTOMEGALOVIRUS COLITIS |
93 |
0.0404 |
| 104 |
BRAIN ABSCESS |
102 |
0.0403 |
| 105 |
GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE |
21 |
0.0401 |
| 106 |
CEREBRAL TOXOPLASMOSIS |
36 |
0.0385 |
| 107 |
TRANSPLANT FAILURE |
93 |
0.0379 |
| 108 |
EYE INFECTION TOXOPLASMAL |
15 |
0.0378 |
| 109 |
LYMPHOCELE |
25 |
0.0377 |
| 110 |
PERIOSTITIS |
16 |
0.0370 |
| 111 |
CYTOMEGALOVIRUS INFECTION |
613 |
0.0368 |
| 112 |
HUMAN HERPESVIRUS 8 INFECTION |
22 |
0.0361 |
| 113 |
SMOOTH MUSCLE CELL NEOPLASM |
15 |
0.0359 |
| 114 |
LIVER TRANSPLANT REJECTION |
64 |
0.0356 |
| 115 |
CEREBRAL ASPERGILLOSIS |
21 |
0.0341 |
| 116 |
NECROTISING OESOPHAGITIS |
17 |
0.0341 |
| 117 |
ENCEPHALITIS VIRAL |
39 |
0.0320 |
| 118 |
VARICELLA ZOSTER VIRUS INFECTION |
66 |
0.0318 |
| 119 |
CORYNEBACTERIUM INFECTION |
17 |
0.0318 |
| 120 |
ENTEROCOCCAL INFECTION |
152 |
0.0314 |
| 121 |
HISTOPLASMOSIS |
55 |
0.0310 |
| 122 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
37 |
0.0308 |
| 123 |
URINARY TRACT DISORDER |
138 |
0.0306 |
| 124 |
MUSCLE ABSCESS |
19 |
0.0305 |
| 125 |
RENAL TUBULAR INJURY |
37 |
0.0305 |
| 126 |
ALVEOLAR PROTEINOSIS |
18 |
0.0304 |
| 127 |
ANOGENITAL WARTS |
27 |
0.0303 |
| 128 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
41 |
0.0297 |
| 129 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
42 |
0.0297 |
| 130 |
HUMAN HERPESVIRUS 6 INFECTION |
56 |
0.0296 |
| 131 |
PNEUMONIA CYTOMEGALOVIRAL |
57 |
0.0293 |
| 132 |
SUPERINFECTION BACTERIAL |
23 |
0.0290 |
| 133 |
EPSTEIN-BARR VIRUS INFECTION |
180 |
0.0288 |
| 134 |
ASPERGILLUS INFECTION |
189 |
0.0288 |
| 135 |
NECROTISING RETINITIS |
18 |
0.0281 |
| 136 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
37 |
0.0281 |
| 137 |
ENTEROVIRUS INFECTION |
24 |
0.0278 |
| 138 |
MEDIASTINITIS |
16 |
0.0276 |
| 139 |
GASTROENTERITIS ESCHERICHIA COLI |
15 |
0.0274 |
| 140 |
METASTATIC SQUAMOUS CELL CARCINOMA |
14 |
0.0274 |
| 141 |
ADENOVIRUS INFECTION |
79 |
0.0272 |
| 142 |
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME |
22 |
0.0271 |
| 143 |
BACILLUS INFECTION |
17 |
0.0269 |
| 144 |
GLOMERULOSCLEROSIS |
17 |
0.0269 |
| 145 |
ENCEPHALOMALACIA |
15 |
0.0266 |
| 146 |
ACINETOBACTER INFECTION |
29 |
0.0265 |
| 147 |
DISSEMINATED TUBERCULOSIS |
68 |
0.0265 |
| 148 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
19 |
0.0265 |
| 149 |
ENTEROBACTER INFECTION |
44 |
0.0262 |
| 150 |
PNEUMONIA PSEUDOMONAL |
40 |
0.0261 |
| 151 |
PAPILLOMA VIRAL INFECTION |
43 |
0.0260 |
| 152 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
195 |
0.0260 |
| 153 |
BRONCHOPULMONARY ASPERGILLOSIS |
201 |
0.0259 |
| 154 |
OSMOTIC DEMYELINATION SYNDROME |
19 |
0.0257 |
| 155 |
VIRAEMIA |
35 |
0.0253 |
| 156 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
23 |
0.0248 |
| 157 |
RENAL TUBULAR DYSFUNCTION |
14 |
0.0248 |
| 158 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
43 |
0.0243 |
| 159 |
GASTROENTERITIS NOROVIRUS |
32 |
0.0241 |
| 160 |
KLEBSIELLA INFECTION |
121 |
0.0239 |
| 161 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
17 |
0.0236 |
| 162 |
LISTERIOSIS |
26 |
0.0235 |
| 163 |
PSEUDOMONAL BACTERAEMIA |
20 |
0.0234 |
| 164 |
TRANSITIONAL CELL CARCINOMA |
30 |
0.0231 |
| 165 |
VIRAL HAEMORRHAGIC CYSTITIS |
16 |
0.0225 |
| 166 |
THROMBOTIC MICROANGIOPATHY |
218 |
0.0223 |
| 167 |
KLEBSIELLA BACTERAEMIA |
21 |
0.0221 |
| 168 |
SYSTEMIC MYCOSIS |
25 |
0.0214 |
| 169 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
58 |
0.0210 |
| 170 |
VASOGENIC CEREBRAL OEDEMA |
15 |
0.0208 |
| 171 |
TOXOPLASMOSIS |
22 |
0.0204 |
| 172 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
89 |
0.0201 |
| 173 |
NOROVIRUS INFECTION |
29 |
0.0201 |
| 174 |
STENOTROPHOMONAS INFECTION |
27 |
0.0199 |
| 175 |
PSEUDOMONAS INFECTION |
167 |
0.0195 |
| 176 |
ACUTE GRAFT VERSUS HOST DISEASE |
89 |
0.0194 |
| 177 |
SEPTIC EMBOLUS |
16 |
0.0192 |
| 178 |
HAEMORRHAGIC STROKE |
150 |
0.0192 |
| 179 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
15 |
0.0190 |
| 180 |
SERRATIA INFECTION |
14 |
0.0188 |
| 181 |
HERPES ZOSTER DISSEMINATED |
15 |
0.0187 |
| 182 |
SECONDARY IMMUNODEFICIENCY |
22 |
0.0181 |
| 183 |
PYELONEPHRITIS ACUTE |
35 |
0.0178 |
| 184 |
GINGIVAL HYPERTROPHY |
27 |
0.0178 |
| 185 |
CHRONIC GRAFT VERSUS HOST DISEASE |
64 |
0.0177 |
| 186 |
RENAL TRANSPLANT |
64 |
0.0177 |
| 187 |
CYSTITIS HAEMORRHAGIC |
71 |
0.0176 |
| 188 |
OBLITERATIVE BRONCHIOLITIS |
23 |
0.0175 |
| 189 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
167 |
0.0175 |
| 190 |
APLASIA PURE RED CELL |
60 |
0.0174 |
| 191 |
MYCOBACTERIAL INFECTION |
30 |
0.0174 |
| 192 |
DISTRIBUTIVE SHOCK |
39 |
0.0172 |
| 193 |
HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME |
19 |
0.0171 |
| 194 |
CYTOMEGALOVIRUS CHORIORETINITIS |
33 |
0.0169 |
| 195 |
FUNGAL SEPSIS |
14 |
0.0168 |
| 196 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
169 |
0.0168 |
| 197 |
DIFFUSE ALVEOLAR DAMAGE |
19 |
0.0165 |
| 198 |
B-CELL LYMPHOMA |
54 |
0.0159 |
| 199 |
CALCIPHYLAXIS |
29 |
0.0158 |
| 200 |
DRUG LEVEL FLUCTUATING |
14 |
0.0158 |
| 201 |
INFECTIOUS PLEURAL EFFUSION |
24 |
0.0158 |
| 202 |
ESCHERICHIA INFECTION |
129 |
0.0157 |
| 203 |
OESOPHAGEAL ULCER |
60 |
0.0156 |
| 204 |
HEART TRANSPLANT |
14 |
0.0155 |
| 205 |
LARGE INTESTINE INFECTION |
19 |
0.0154 |
| 206 |
NASAL CAVITY CANCER |
14 |
0.0153 |
| 207 |
SYSTEMIC INFECTION |
25 |
0.0151 |
| 208 |
HYPOGAMMAGLOBULINAEMIA |
99 |
0.0151 |
| 209 |
VACCINATION FAILURE |
25 |
0.0150 |
| 210 |
GLOMERULONEPHRITIS |
36 |
0.0147 |
| 211 |
BILIARY OBSTRUCTION |
19 |
0.0146 |
| 212 |
GRAFT VERSUS HOST DISEASE |
103 |
0.0143 |
| 213 |
PNEUMOPERITONEUM |
26 |
0.0141 |
| 214 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
70 |
0.0140 |
| 215 |
ILEAL ULCER |
14 |
0.0138 |
| 216 |
PNEUMONIA FUNGAL |
54 |
0.0137 |
| 217 |
NEPHROPATHY TOXIC |
153 |
0.0136 |
| 218 |
GENERALISED OEDEMA |
166 |
0.0134 |
| 219 |
PNEUMONIA LEGIONELLA |
21 |
0.0131 |
| 220 |
HAEMATOLOGICAL INFECTION |
32 |
0.0131 |
| 221 |
SALMONELLOSIS |
22 |
0.0130 |
| 222 |
ESCHERICHIA BACTERAEMIA |
30 |
0.0127 |
| 223 |
OCULAR DISCOMFORT |
143 |
0.0127 |
| 224 |
PNEUMOCYSTIS JIROVECII INFECTION |
15 |
0.0126 |
| 225 |
PNEUMONIA KLEBSIELLA |
23 |
0.0125 |
| 226 |
CYTOMEGALOVIRUS TEST POSITIVE |
22 |
0.0123 |
| 227 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
13 |
0.0122 |
| 228 |
DIFFUSE LARGE B-CELL LYMPHOMA |
94 |
0.0122 |
| 229 |
PNEUMOMEDIASTINUM |
22 |
0.0122 |
| 230 |
HAEMOLYTIC URAEMIC SYNDROME |
28 |
0.0121 |
| 231 |
STEROID DIABETES |
18 |
0.0120 |
| 232 |
BACTERIAL SEPSIS |
39 |
0.0120 |
| 233 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
338 |
0.0119 |
| 234 |
ACARODERMATITIS |
13 |
0.0119 |
| 235 |
URINARY TRACT INFECTION BACTERIAL |
30 |
0.0119 |
| 236 |
RENAL TUBULAR NECROSIS |
116 |
0.0118 |
| 237 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
96 |
0.0116 |
| 238 |
EMPYEMA |
23 |
0.0116 |
| 239 |
HERPES SIMPLEX |
75 |
0.0115 |
| 240 |
MYASTHENIA GRAVIS CRISIS |
17 |
0.0115 |
| 241 |
FUNGAEMIA |
18 |
0.0114 |
| 242 |
MENINGITIS BACTERIAL |
16 |
0.0112 |
| 243 |
HYPERPARATHYROIDISM SECONDARY |
28 |
0.0112 |
| 244 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
16 |
0.0110 |
| 245 |
COCCIDIOIDOMYCOSIS |
13 |
0.0109 |
| 246 |
OESOPHAGEAL STENOSIS |
31 |
0.0109 |
| 247 |
DRUG LEVEL INCREASED |
180 |
0.0109 |
| 248 |
IGA NEPHROPATHY |
18 |
0.0108 |
| 249 |
SQUAMOUS CELL CARCINOMA OF SKIN |
65 |
0.0108 |
| 250 |
PYELONEPHRITIS |
93 |
0.0107 |
| 251 |
ESCHERICHIA SEPSIS |
31 |
0.0107 |
| 252 |
LARGE INTESTINAL ULCER |
29 |
0.0107 |
| 253 |
COVID-19 PNEUMONIA |
126 |
0.0107 |
| 254 |
ATYPICAL MYCOBACTERIAL INFECTION |
15 |
0.0106 |
| 255 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
15 |
0.0104 |
| 256 |
NORMOCYTIC ANAEMIA |
15 |
0.0102 |
| 257 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
180 |
0.0102 |
| 258 |
DRUG LEVEL ABOVE THERAPEUTIC |
46 |
0.0100 |
| 259 |
ORGANISING PNEUMONIA |
49 |
0.0099 |
| 260 |
ESCHERICHIA URINARY TRACT INFECTION |
41 |
0.0096 |
| 261 |
RHINOVIRUS INFECTION |
37 |
0.0095 |
| 262 |
PNEUMATOSIS INTESTINALIS |
27 |
0.0095 |
| 263 |
PNEUMONIA PNEUMOCOCCAL |
14 |
0.0094 |
| 264 |
PROTEINURIA |
178 |
0.0094 |
| 265 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
25 |
0.0093 |
| 266 |
ENCEPHALITIS |
64 |
0.0092 |
| 267 |
METASTATIC MALIGNANT MELANOMA |
21 |
0.0091 |
| 268 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
18 |
0.0091 |
| 269 |
BRAIN HERNIATION |
27 |
0.0090 |
| 270 |
BACTERAEMIA |
107 |
0.0090 |
| 271 |
HYDRONEPHROSIS |
67 |
0.0089 |
| 272 |
GRANULOMA |
30 |
0.0087 |
| 273 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
23 |
0.0086 |
| 274 |
LUNG CONSOLIDATION |
24 |
0.0086 |
| 275 |
BRADYARRHYTHMIA |
14 |
0.0085 |
| 276 |
PNEUMONIA VIRAL |
27 |
0.0085 |
| 277 |
HEPATIC FIBROSIS |
29 |
0.0084 |
| 278 |
PATHOGEN RESISTANCE |
77 |
0.0084 |
| 279 |
CUSHINGOID |
27 |
0.0084 |
| 280 |
HEAD DISCOMFORT |
147 |
0.0083 |
| 281 |
HYPERVOLAEMIA |
41 |
0.0083 |
| 282 |
SEPTIC SHOCK |
359 |
0.0082 |
| 283 |
SOFT TISSUE INFECTION |
15 |
0.0082 |
| 284 |
BLOOD IMMUNOGLOBULIN G DECREASED |
20 |
0.0081 |
| 285 |
MYASTHENIA GRAVIS |
65 |
0.0080 |
| 286 |
OESOPHAGEAL CANDIDIASIS |
32 |
0.0080 |
| 287 |
PULMONARY ALVEOLAR HAEMORRHAGE |
45 |
0.0080 |
| 288 |
CANDIDA INFECTION |
135 |
0.0080 |
| 289 |
BONE EROSION |
28 |
0.0079 |
| 290 |
VENOOCCLUSIVE LIVER DISEASE |
39 |
0.0079 |
| 291 |
PHOTOPHOBIA |
146 |
0.0078 |
| 292 |
AZOTAEMIA |
31 |
0.0078 |
| 293 |
NEPHROTIC SYNDROME |
53 |
0.0077 |
| 294 |
SCLERODERMA |
28 |
0.0077 |
| 295 |
SYSTEMIC CANDIDA |
19 |
0.0076 |
| 296 |
POSTOPERATIVE WOUND INFECTION |
51 |
0.0075 |
| 297 |
ACUTE SINUSITIS |
13 |
0.0075 |
| 298 |
DUODENITIS |
23 |
0.0075 |
| 299 |
HAEMATURIA |
255 |
0.0074 |
| 300 |
ACUTE RESPIRATORY FAILURE |
142 |
0.0074 |
| 301 |
UROSEPSIS |
68 |
0.0074 |
| 302 |
LYMPHOPENIA |
104 |
0.0073 |
| 303 |
RENAL TUBULAR ACIDOSIS |
16 |
0.0073 |
| 304 |
HEPATITIS B REACTIVATION |
23 |
0.0072 |
| 305 |
HEPATIC NECROSIS |
27 |
0.0072 |
| 306 |
TRANSPLANT |
17 |
0.0072 |
| 307 |
OPTIC NEUROPATHY |
15 |
0.0071 |
| 308 |
GENE MUTATION |
14 |
0.0071 |
| 309 |
ALTERED STATE OF CONSCIOUSNESS |
151 |
0.0070 |
| 310 |
FUNGAL SKIN INFECTION |
28 |
0.0069 |
| 311 |
NEUROLOGICAL DECOMPENSATION |
16 |
0.0069 |
| 312 |
LEUKOPENIA |
343 |
0.0069 |
| 313 |
LYMPHOPROLIFERATIVE DISORDER |
20 |
0.0068 |
| 314 |
END STAGE RENAL DISEASE |
124 |
0.0068 |
| 315 |
GASTROINTESTINAL ULCER |
15 |
0.0068 |
| 316 |
STAPHYLOCOCCAL BACTERAEMIA |
29 |
0.0067 |
| 317 |
NECROTISING FASCIITIS |
23 |
0.0065 |
| 318 |
NEPHROGENIC ANAEMIA |
30 |
0.0065 |
| 319 |
HISTIOCYTOSIS HAEMATOPHAGIC |
19 |
0.0064 |
| 320 |
ASCITES |
188 |
0.0064 |
| 321 |
DERMATOMYOSITIS |
16 |
0.0063 |
| 322 |
NEPHRITIS |
21 |
0.0063 |
| 323 |
ABDOMINAL INFECTION |
16 |
0.0063 |
| 324 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
21 |
0.0061 |
| 325 |
BRONCHIECTASIS |
41 |
0.0061 |
| 326 |
CD4 LYMPHOCYTES DECREASED |
13 |
0.0061 |
| 327 |
SQUAMOUS CELL CARCINOMA |
57 |
0.0060 |
| 328 |
ENDOCARDITIS |
31 |
0.0060 |
| 329 |
HAEMATEMESIS |
153 |
0.0060 |
| 330 |
ACUTE KIDNEY INJURY |
922 |
0.0060 |
| 331 |
DIPLOPIA |
156 |
0.0060 |
| 332 |
VENOOCCLUSIVE DISEASE |
15 |
0.0060 |
| 333 |
SKIN NECROSIS |
31 |
0.0060 |
| 334 |
PRESYNCOPE |
145 |
0.0060 |
| 335 |
CLOSTRIDIUM DIFFICILE COLITIS |
63 |
0.0059 |
| 336 |
HAEMODYNAMIC INSTABILITY |
45 |
0.0059 |
| 337 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
20 |
0.0058 |
| 338 |
RENAL IMPAIRMENT |
483 |
0.0057 |
| 339 |
PROCTITIS |
16 |
0.0057 |
| 340 |
BACTERIAL INFECTION |
106 |
0.0057 |
| 341 |
NEPHROPATHY |
53 |
0.0057 |
| 342 |
LUNG TRANSPLANT |
20 |
0.0056 |
| 343 |
CHOLANGITIS |
35 |
0.0056 |
| 344 |
ENCEPHALOPATHY |
137 |
0.0056 |
| 345 |
LIVER TRANSPLANT |
20 |
0.0055 |
| 346 |
RESPIRATORY FAILURE |
399 |
0.0055 |
| 347 |
HAEMOLYTIC ANAEMIA |
49 |
0.0055 |
| 348 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
19 |
0.0054 |
| 349 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
20 |
0.0053 |
| 350 |
OLIGURIA |
33 |
0.0053 |
| 351 |
SKIN PAPILLOMA |
21 |
0.0052 |
| 352 |
PNEUMONIA BACTERIAL |
48 |
0.0052 |
| 353 |
INTRACRANIAL PRESSURE INCREASED |
29 |
0.0052 |
| 354 |
BRAIN DEATH |
16 |
0.0052 |
| 355 |
NEUROTOXICITY |
90 |
0.0051 |
| 356 |
TUBULOINTERSTITIAL NEPHRITIS |
96 |
0.0051 |
| 357 |
SEPSIS |
562 |
0.0050 |
| 358 |
BLOOD CREATININE INCREASED |
328 |
0.0050 |
| 359 |
PROTEIN URINE PRESENT |
25 |
0.0050 |
| 360 |
PYODERMA GANGRENOSUM |
18 |
0.0050 |
| 361 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
19 |
0.0050 |
| 362 |
LARGE INTESTINE PERFORATION |
34 |
0.0049 |
| 363 |
ARTHRITIS BACTERIAL |
20 |
0.0049 |
| 364 |
DRUG RESISTANCE |
125 |
0.0049 |
| 365 |
ELECTROLYTE IMBALANCE |
56 |
0.0048 |
| 366 |
HYPERAMMONAEMIA |
24 |
0.0048 |
| 367 |
PULSELESS ELECTRICAL ACTIVITY |
20 |
0.0048 |
| 368 |
HYPOVOLAEMIA |
28 |
0.0048 |
| 369 |
METASTASES TO LYMPH NODES |
32 |
0.0047 |
| 370 |
SHOCK HAEMORRHAGIC |
38 |
0.0047 |
| 371 |
HEPATITIS CHOLESTATIC |
28 |
0.0046 |
| 372 |
IMMUNOSUPPRESSION |
41 |
0.0046 |
| 373 |
ANAL HAEMORRHAGE |
13 |
0.0046 |
| 374 |
COMA |
221 |
0.0046 |
| 375 |
DRUG INTERACTION |
736 |
0.0046 |
| 376 |
BLOOD CREATININE ABNORMAL |
16 |
0.0046 |
| 377 |
LIVER ABSCESS |
15 |
0.0046 |
| 378 |
HYPERKALAEMIA |
162 |
0.0046 |
| 379 |
COVID-19 |
805 |
0.0046 |
| 380 |
MYOSITIS |
41 |
0.0046 |
| 381 |
FIBROSIS |
14 |
0.0045 |
| 382 |
BLOOD CREATINE INCREASED |
20 |
0.0045 |
| 383 |
PANCYTOPENIA |
252 |
0.0045 |
| 384 |
CYTOPENIA |
55 |
0.0045 |
| 385 |
STAPHYLOCOCCAL SEPSIS |
22 |
0.0045 |
| 386 |
WOUND DEHISCENCE |
15 |
0.0044 |
| 387 |
PAPILLOEDEMA |
20 |
0.0044 |
| 388 |
CORONAVIRUS INFECTION |
29 |
0.0044 |
| 389 |
ENTERITIS |
28 |
0.0044 |
| 390 |
ABDOMINAL ABSCESS |
19 |
0.0043 |
| 391 |
HYPERCALCAEMIA |
53 |
0.0043 |
| 392 |
DUODENAL ULCER |
30 |
0.0042 |
| 393 |
DISEASE RECURRENCE |
201 |
0.0042 |
| 394 |
APLASTIC ANAEMIA |
22 |
0.0042 |
| 395 |
BLINDNESS |
171 |
0.0042 |
| 396 |
MYOPATHY |
36 |
0.0042 |
| 397 |
GUILLAIN-BARRE SYNDROME |
20 |
0.0041 |
| 398 |
PRE-ECLAMPSIA |
19 |
0.0040 |
| 399 |
HERPES VIRUS INFECTION |
23 |
0.0040 |
| 400 |
SUSPECTED OFF LABEL USE |
18 |
0.0040 |
| 401 |
DISSEMINATED INTRAVASCULAR COAGULATION |
56 |
0.0040 |
| 402 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
216 |
0.0039 |
| 403 |
ATELECTASIS |
38 |
0.0039 |
| 404 |
HYPOPHOSPHATAEMIA |
29 |
0.0039 |
| 405 |
LEUKOCYTOSIS |
71 |
0.0039 |
| 406 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
139 |
0.0039 |
| 407 |
CARDIO-RESPIRATORY ARREST |
159 |
0.0038 |
| 408 |
CARDIAC DYSFUNCTION |
14 |
0.0038 |
| 409 |
PULMONARY MASS |
56 |
0.0038 |
| 410 |
GASTROINTESTINAL TOXICITY |
18 |
0.0037 |
| 411 |
MENINGITIS |
25 |
0.0037 |
| 412 |
C-REACTIVE PROTEIN ABNORMAL |
24 |
0.0037 |
| 413 |
SHOCK |
86 |
0.0037 |
| 414 |
DISEASE COMPLICATION |
17 |
0.0037 |
| 415 |
FUNGAL INFECTION |
123 |
0.0037 |
| 416 |
METABOLIC ACIDOSIS |
118 |
0.0037 |
| 417 |
INFLAMMATORY BOWEL DISEASE |
36 |
0.0037 |
| 418 |
RESPIRATORY DISTRESS |
101 |
0.0037 |
| 419 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
27 |
0.0036 |
| 420 |
ENTEROCOLITIS |
21 |
0.0036 |
| 421 |
STAPHYLOCOCCAL INFECTION |
119 |
0.0036 |
| 422 |
OESOPHAGITIS |
39 |
0.0036 |
| 423 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
31 |
0.0036 |
| 424 |
TOXIC ENCEPHALOPATHY |
18 |
0.0035 |
| 425 |
HEPATIC ENCEPHALOPATHY |
33 |
0.0035 |
| 426 |
HAEMOLYSIS |
27 |
0.0035 |
| 427 |
CLOSTRIDIUM DIFFICILE INFECTION |
76 |
0.0035 |
| 428 |
FAILURE TO THRIVE |
18 |
0.0035 |
| 429 |
NONSPECIFIC REACTION |
19 |
0.0035 |
| 430 |
MALIGNANT MELANOMA |
46 |
0.0034 |
| 431 |
CATATONIA |
18 |
0.0034 |
| 432 |
GLOMERULAR FILTRATION RATE DECREASED |
42 |
0.0034 |
| 433 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
35 |
0.0034 |
| 434 |
ACIDOSIS |
26 |
0.0034 |
| 435 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
30 |
0.0034 |
| 436 |
SKIN INFECTION |
38 |
0.0034 |
| 437 |
ABNORMAL LOSS OF WEIGHT |
23 |
0.0034 |
| 438 |
ACUTE HEPATIC FAILURE |
46 |
0.0034 |
| 439 |
IRON DEFICIENCY ANAEMIA |
31 |
0.0034 |
| 440 |
ODYNOPHAGIA |
20 |
0.0033 |
| 441 |
HYPOVOLAEMIC SHOCK |
16 |
0.0033 |
| 442 |
ENDOPHTHALMITIS |
20 |
0.0033 |
| 443 |
PULMONARY TUBERCULOSIS |
14 |
0.0033 |
| 444 |
INTESTINAL ISCHAEMIA |
18 |
0.0033 |
| 445 |
CEREBRAL ATROPHY |
13 |
0.0033 |
| 446 |
ANURIA |
28 |
0.0033 |
| 447 |
STREPTOCOCCAL INFECTION |
18 |
0.0032 |
| 448 |
NECROSIS |
18 |
0.0032 |
| 449 |
RENAL FUNCTION TEST ABNORMAL |
15 |
0.0032 |
| 450 |
PULMONARY FUNCTION TEST DECREASED |
14 |
0.0032 |
| 451 |
CORONARY ARTERY STENOSIS |
16 |
0.0032 |
| 452 |
THERAPY NON-RESPONDER |
143 |
0.0032 |
| 453 |
PEMPHIGOID |
24 |
0.0032 |
| 454 |
MOUTH ULCERATION |
67 |
0.0032 |
| 455 |
LUNG INFILTRATION |
28 |
0.0032 |
| 456 |
BRAIN OEDEMA |
40 |
0.0032 |
| 457 |
TINNITUS |
145 |
0.0032 |
| 458 |
HEPATITIS B |
19 |
0.0031 |
| 459 |
CARDIAC FAILURE ACUTE |
21 |
0.0031 |
| 460 |
ISCHAEMIC STROKE |
56 |
0.0031 |
| 461 |
PRODUCT USE IN UNAPPROVED INDICATION |
773 |
0.0031 |
| 462 |
BLOOD URIC ACID INCREASED |
18 |
0.0031 |
| 463 |
DIVERTICULITIS |
86 |
0.0031 |
| 464 |
REBOUND EFFECT |
35 |
0.0031 |
| 465 |
HYPOMAGNESAEMIA |
43 |
0.0031 |
| 466 |
COLITIS |
117 |
0.0031 |
| 467 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
34 |
0.0031 |
| 468 |
EYE PAIN |
173 |
0.0031 |
| 469 |
RENAL CELL CARCINOMA |
15 |
0.0031 |
| 470 |
GOUT |
55 |
0.0031 |
| 471 |
THERAPY CHANGE |
30 |
0.0030 |
| 472 |
DRUG LEVEL DECREASED |
31 |
0.0030 |
| 473 |
HEPATOCELLULAR CARCINOMA |
23 |
0.0030 |
| 474 |
WOUND INFECTION |
33 |
0.0030 |
| 475 |
ARTERIOSCLEROSIS |
28 |
0.0030 |
| 476 |
HEPATOTOXICITY |
66 |
0.0030 |
| 477 |
HYPOXIA |
104 |
0.0030 |
| 478 |
GASTROINTESTINAL DISORDER |
263 |
0.0029 |
| 479 |
GENERALISED TONIC-CLONIC SEIZURE |
48 |
0.0029 |
| 480 |
HEPATITIS C |
35 |
0.0029 |
| 481 |
DIALYSIS |
41 |
0.0029 |
| 482 |
OSTEOMYELITIS |
52 |
0.0029 |
| 483 |
ANGIOPATHY |
16 |
0.0029 |
| 484 |
MENTAL STATUS CHANGES |
79 |
0.0028 |
| 485 |
PNEUMOTHORAX |
45 |
0.0028 |
| 486 |
TACHYCARDIA |
252 |
0.0028 |
| 487 |
NEUTROPENIA |
385 |
0.0028 |
| 488 |
INFLAMMATORY MARKER INCREASED |
14 |
0.0028 |
| 489 |
GASTROENTERITIS |
41 |
0.0028 |
| 490 |
MYOCARDITIS |
32 |
0.0028 |
| 491 |
PULMONARY FIBROSIS |
53 |
0.0028 |
| 492 |
BASAL CELL CARCINOMA |
43 |
0.0028 |
| 493 |
INTERSTITIAL LUNG DISEASE |
131 |
0.0027 |
| 494 |
ABSCESS |
43 |
0.0027 |
| 495 |
BONE MARROW FAILURE |
54 |
0.0027 |
| 496 |
HEMIPARESIS |
45 |
0.0027 |
| 497 |
THERAPY PARTIAL RESPONDER |
41 |
0.0026 |
| 498 |
OFF LABEL USE |
2300 |
0.0026 |
| 499 |
FOOD POISONING |
14 |
0.0026 |
| 500 |
PNEUMONIA ASPIRATION |
65 |
0.0026 |
| 501 |
SMALL INTESTINAL OBSTRUCTION |
32 |
0.0026 |
| 502 |
HYPERTRANSAMINASAEMIA |
18 |
0.0026 |
| 503 |
HYPOALBUMINAEMIA |
20 |
0.0026 |
| 504 |
HYDROCEPHALUS |
14 |
0.0026 |
| 505 |
POLYURIA |
21 |
0.0026 |
| 506 |
HYPERTRIGLYCERIDAEMIA |
15 |
0.0026 |
| 507 |
INFUSION SITE PAIN |
33 |
0.0026 |
| 508 |
DYSLIPIDAEMIA |
13 |
0.0026 |
| 509 |
TREATMENT FAILURE |
211 |
0.0025 |
| 510 |
PLEURAL EFFUSION |
154 |
0.0025 |
| 511 |
MUCOSAL INFLAMMATION |
66 |
0.0025 |
| 512 |
SKIN LESION |
69 |
0.0025 |
| 513 |
TOXICITY TO VARIOUS AGENTS |
424 |
0.0025 |
| 514 |
PREMATURE DELIVERY |
40 |
0.0025 |
| 515 |
HYPERGLYCAEMIA |
91 |
0.0025 |
| 516 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
17 |
0.0025 |
| 517 |
HEPATIC FAILURE |
75 |
0.0025 |
| 518 |
TRANSAMINASES INCREASED |
55 |
0.0025 |
| 519 |
PERICARDIAL EFFUSION |
57 |
0.0025 |
| 520 |
FACIAL PARALYSIS |
21 |
0.0025 |
| 521 |
PNEUMONITIS |
67 |
0.0025 |
| 522 |
URINARY TRACT INFECTION |
419 |
0.0025 |
| 523 |
NEUROLOGICAL SYMPTOM |
14 |
0.0024 |
| 524 |
CHRONIC KIDNEY DISEASE |
186 |
0.0024 |
| 525 |
AUTOIMMUNE HEPATITIS |
17 |
0.0024 |
| 526 |
CEREBRAL INFARCTION |
59 |
0.0024 |
| 527 |
ATRIOVENTRICULAR BLOCK COMPLETE |
16 |
0.0024 |
| 528 |
VIRAL INFECTION |
79 |
0.0024 |
| 529 |
GLUCOSE TOLERANCE IMPAIRED |
14 |
0.0024 |
| 530 |
CHILLS |
277 |
0.0024 |
| 531 |
INFECTION |
341 |
0.0024 |
| 532 |
DIARRHOEA HAEMORRHAGIC |
22 |
0.0024 |
| 533 |
METASTASES TO LUNG |
27 |
0.0023 |
| 534 |
VASCULITIS |
27 |
0.0023 |
| 535 |
KIDNEY INFECTION |
45 |
0.0023 |
| 536 |
DRUG INTOLERANCE |
221 |
0.0023 |
| 537 |
PERITONITIS BACTERIAL |
23 |
0.0023 |
| 538 |
MULTI-ORGAN FAILURE |
39 |
0.0023 |
| 539 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
66 |
0.0023 |
| 540 |
SKIN MASS |
15 |
0.0022 |
| 541 |
PEMPHIGUS |
28 |
0.0022 |
| 542 |
CARDIOGENIC SHOCK |
32 |
0.0022 |
| 543 |
PYREXIA |
766 |
0.0022 |
| 544 |
HAEMATOTOXICITY |
21 |
0.0022 |
| 545 |
HAEMATOMA |
57 |
0.0022 |
| 546 |
HEPATITIS ACUTE |
14 |
0.0022 |
| 547 |
RENAL FAILURE |
286 |
0.0022 |
| 548 |
AGRANULOCYTOSIS |
40 |
0.0021 |
| 549 |
RESPIRATORY TRACT INFECTION |
56 |
0.0021 |
| 550 |
PERICARDITIS |
36 |
0.0021 |
| 551 |
UVEITIS |
29 |
0.0021 |
| 552 |
CARDIOTOXICITY |
19 |
0.0021 |
| 553 |
PERITONITIS |
44 |
0.0021 |
| 554 |
LUNG INFECTION |
33 |
0.0021 |
| 555 |
WALKING AID USER |
14 |
0.0021 |
| 556 |
TREATMENT NONCOMPLIANCE |
116 |
0.0021 |
| 557 |
SENSORY LOSS |
17 |
0.0021 |
| 558 |
SYNOVITIS |
38 |
0.0021 |
| 559 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
36 |
0.0021 |
| 560 |
THERAPY INTERRUPTED |
150 |
0.0021 |
| 561 |
THROMBOCYTOPENIA |
234 |
0.0021 |
| 562 |
ILEUS |
26 |
0.0021 |
| 563 |
PANCREATITIS ACUTE |
47 |
0.0021 |
| 564 |
DEVICE RELATED INFECTION |
32 |
0.0021 |
| 565 |
TACHYPNOEA |
28 |
0.0021 |
| 566 |
INTESTINAL PERFORATION |
23 |
0.0020 |
| 567 |
COAGULOPATHY |
34 |
0.0020 |
| 568 |
BLOOD UREA INCREASED |
34 |
0.0020 |
| 569 |
LARGE INTESTINE POLYP |
14 |
0.0020 |
| 570 |
QUALITY OF LIFE DECREASED |
27 |
0.0020 |
| 571 |
LACTIC ACIDOSIS |
65 |
0.0020 |
| 572 |
GASTRIC ULCER |
38 |
0.0020 |
| 573 |
CYTOKINE RELEASE SYNDROME |
40 |
0.0020 |
| 574 |
OSTEOPOROSIS |
82 |
0.0020 |
| 575 |
C-REACTIVE PROTEIN INCREASED |
72 |
0.0020 |
| 576 |
OSTEOPENIA |
30 |
0.0020 |
| 577 |
ORAL CANDIDIASIS |
26 |
0.0020 |
| 578 |
IMMUNE SYSTEM DISORDER |
26 |
0.0020 |
| 579 |
PULMONARY HYPERTENSION |
41 |
0.0020 |
| 580 |
CENTRAL NERVOUS SYSTEM LESION |
27 |
0.0020 |
| 581 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
33 |
0.0020 |
| 582 |
ULCER |
31 |
0.0019 |
| 583 |
DRUG-INDUCED LIVER INJURY |
61 |
0.0019 |
| 584 |
MITRAL VALVE INCOMPETENCE |
22 |
0.0019 |
| 585 |
PNEUMONIA |
628 |
0.0019 |
| 586 |
HYPERBILIRUBINAEMIA |
20 |
0.0019 |
| 587 |
ABDOMINAL PAIN |
447 |
0.0019 |
| 588 |
HYPOTONIA |
19 |
0.0019 |
| 589 |
ANAEMIA |
362 |
0.0019 |
| 590 |
GASTROINTESTINAL INFECTION |
17 |
0.0019 |
| 591 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
30 |
0.0019 |
| 592 |
MATERNAL EXPOSURE DURING PREGNANCY |
168 |
0.0019 |
| 593 |
BLOOD SODIUM DECREASED |
35 |
0.0019 |
| 594 |
HELICOBACTER INFECTION |
19 |
0.0018 |
| 595 |
CHOLECYSTITIS |
22 |
0.0018 |
| 596 |
VITAMIN D DEFICIENCY |
18 |
0.0018 |
| 597 |
FEBRILE NEUTROPENIA |
122 |
0.0018 |
| 598 |
INTERNAL HAEMORRHAGE |
21 |
0.0018 |
| 599 |
COELIAC DISEASE |
18 |
0.0018 |
| 600 |
BLOOD PRESSURE INCREASED |
280 |
0.0018 |
| 601 |
DIVERTICULUM |
13 |
0.0018 |
| 602 |
HERPES ZOSTER |
105 |
0.0018 |
| 603 |
GASTRITIS |
48 |
0.0018 |
| 604 |
SKIN ULCER |
47 |
0.0018 |
| 605 |
CARDIAC ARREST |
150 |
0.0018 |
| 606 |
ACUTE CORONARY SYNDROME |
15 |
0.0018 |
| 607 |
PULMONARY OEDEMA |
81 |
0.0018 |
| 608 |
SUPRAVENTRICULAR TACHYCARDIA |
17 |
0.0018 |
| 609 |
CONDITION AGGRAVATED |
539 |
0.0018 |
| 610 |
RENAL DISORDER |
82 |
0.0018 |
| 611 |
UPPER RESPIRATORY TRACT INFECTION |
81 |
0.0018 |
| 612 |
DYSPNOEA EXERTIONAL |
66 |
0.0018 |
| 613 |
ASPIRATION |
19 |
0.0017 |
| 614 |
DIABETES MELLITUS |
132 |
0.0017 |
| 615 |
SYNCOPE |
173 |
0.0017 |
| 616 |
LYMPHADENOPATHY |
61 |
0.0017 |
| 617 |
DIARRHOEA |
1110 |
0.0017 |
| 618 |
FLUID OVERLOAD |
25 |
0.0017 |
| 619 |
PRODUCTIVE COUGH |
82 |
0.0017 |
| 620 |
URINE OUTPUT DECREASED |
15 |
0.0017 |
| 621 |
LUNG DISORDER |
84 |
0.0017 |
| 622 |
PARALYSIS |
24 |
0.0017 |
| 623 |
HYPONATRAEMIA |
94 |
0.0017 |
| 624 |
INFLAMMATION |
86 |
0.0017 |
| 625 |
DIABETIC KETOACIDOSIS |
40 |
0.0017 |
| 626 |
DISEASE PROGRESSION |
197 |
0.0017 |
| 627 |
INFUSION SITE ERYTHEMA |
14 |
0.0017 |
| 628 |
METASTASES TO LIVER |
29 |
0.0016 |
| 629 |
HIDRADENITIS |
15 |
0.0016 |
| 630 |
AUTOIMMUNE DISORDER |
16 |
0.0016 |
| 631 |
HAEMORRHOIDS |
32 |
0.0016 |
| 632 |
ORAL HERPES |
32 |
0.0016 |
| 633 |
SCIATICA |
26 |
0.0016 |
| 634 |
LIVER INJURY |
40 |
0.0016 |
| 635 |
CHOLESTASIS |
31 |
0.0016 |
| 636 |
DELIRIUM |
56 |
0.0016 |
| 637 |
COUGH |
452 |
0.0016 |
| 638 |
APPENDICITIS |
15 |
0.0016 |
| 639 |
EYELID PTOSIS |
16 |
0.0016 |
| 640 |
ABORTION SPONTANEOUS |
63 |
0.0016 |
| 641 |
CELLULITIS |
79 |
0.0016 |
| 642 |
ADRENAL INSUFFICIENCY |
19 |
0.0016 |
| 643 |
HEPATIC CIRRHOSIS |
29 |
0.0015 |
| 644 |
HAEMOPTYSIS |
43 |
0.0015 |
| 645 |
BLOOD POTASSIUM INCREASED |
25 |
0.0015 |
| 646 |
VISION BLURRED |
209 |
0.0015 |
| 647 |
INTENTIONAL PRODUCT USE ISSUE |
133 |
0.0015 |
| 648 |
ABDOMINAL PAIN UPPER |
312 |
0.0015 |
| 649 |
STATUS EPILEPTICUS |
17 |
0.0015 |
| 650 |
DYSURIA |
55 |
0.0015 |
| 651 |
BLOOD PRESSURE FLUCTUATION |
35 |
0.0015 |
| 652 |
MYALGIA |
247 |
0.0015 |
| 653 |
OXYGEN SATURATION DECREASED |
81 |
0.0014 |
| 654 |
SKIN CANCER |
31 |
0.0014 |
| 655 |
APHONIA |
20 |
0.0014 |
| 656 |
DERMATITIS |
30 |
0.0014 |
| 657 |
MALNUTRITION |
16 |
0.0014 |
| 658 |
BLOOD TEST ABNORMAL |
20 |
0.0014 |
| 659 |
FISTULA |
16 |
0.0014 |
| 660 |
HYPERLIPIDAEMIA |
17 |
0.0014 |
| 661 |
IMMUNODEFICIENCY |
21 |
0.0014 |
| 662 |
HYPOPHAGIA |
36 |
0.0014 |
| 663 |
INTENTIONAL DOSE OMISSION |
40 |
0.0014 |
| 664 |
CONTRAINDICATED PRODUCT ADMINISTERED |
42 |
0.0014 |
| 665 |
FLUID RETENTION |
70 |
0.0014 |
| 666 |
HOSPITALISATION |
211 |
0.0014 |
| 667 |
IMPAIRED HEALING |
45 |
0.0014 |
| 668 |
SPLENOMEGALY |
16 |
0.0014 |
| 669 |
HYPOKALAEMIA |
63 |
0.0014 |
| 670 |
CYSTITIS |
43 |
0.0013 |
| 671 |
HAEMOGLOBIN DECREASED |
138 |
0.0013 |
| 672 |
TENDERNESS |
14 |
0.0013 |
| 673 |
FOLLICULITIS |
14 |
0.0013 |
| 674 |
BLOOD PRESSURE SYSTOLIC INCREASED |
26 |
0.0013 |
| 675 |
GASTROENTERITIS VIRAL |
24 |
0.0013 |
| 676 |
SOMNOLENCE |
267 |
0.0013 |
| 677 |
DECREASED APPETITE |
306 |
0.0013 |
| 678 |
GASTROOESOPHAGEAL REFLUX DISEASE |
106 |
0.0013 |
| 679 |
MYELODYSPLASTIC SYNDROME |
19 |
0.0013 |
| 680 |
EOSINOPHILIA |
23 |
0.0013 |
| 681 |
INSURANCE ISSUE |
20 |
0.0013 |
| 682 |
POST PROCEDURAL COMPLICATION |
25 |
0.0013 |
| 683 |
MASS |
18 |
0.0013 |
| 684 |
CARDIOMYOPATHY |
19 |
0.0013 |
| 685 |
ACUTE MYELOID LEUKAEMIA |
20 |
0.0013 |
| 686 |
HALLUCINATION, VISUAL |
27 |
0.0013 |
| 687 |
SECRETION DISCHARGE |
16 |
0.0013 |
| 688 |
BRAIN FOG |
20 |
0.0013 |
| 689 |
LIVER FUNCTION TEST ABNORMAL |
37 |
0.0013 |
| 690 |
CARDIAC FAILURE |
102 |
0.0013 |
| 691 |
GENERAL PHYSICAL HEALTH DETERIORATION |
147 |
0.0013 |
| 692 |
MUSCLE ATROPHY |
16 |
0.0013 |
| 693 |
CATARACT |
75 |
0.0013 |
| 694 |
HEPATITIS |
32 |
0.0012 |
| 695 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
60 |
0.0012 |
| 696 |
DEHYDRATION |
166 |
0.0012 |
| 697 |
VOMITING |
585 |
0.0012 |
| 698 |
PULMONARY ARTERIAL HYPERTENSION |
18 |
0.0012 |
| 699 |
LOCALISED INFECTION |
30 |
0.0012 |
| 700 |
BLOOD BILIRUBIN INCREASED |
33 |
0.0012 |
| 701 |
MYELOSUPPRESSION |
43 |
0.0012 |
| 702 |
ABDOMINAL PAIN LOWER |
30 |
0.0012 |
| 703 |
GASTROINTESTINAL HAEMORRHAGE |
99 |
0.0012 |
| 704 |
DRUG INEFFECTIVE |
1556 |
0.0012 |
| 705 |
OEDEMA |
64 |
0.0012 |
| 706 |
BLOOD IRON DECREASED |
14 |
0.0012 |
| 707 |
NIGHT SWEATS |
38 |
0.0012 |
| 708 |
INFLUENZA |
131 |
0.0012 |
| 709 |
PRODUCT DOSE OMISSION IN ERROR |
33 |
0.0012 |
| 710 |
HYPOCALCAEMIA |
22 |
0.0012 |
| 711 |
BLOOD URINE PRESENT |
22 |
0.0012 |
| 712 |
HYPERTENSION |
245 |
0.0012 |
| 713 |
BURSITIS |
14 |
0.0012 |
| 714 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
82 |
0.0012 |
| 715 |
PHOTOSENSITIVITY REACTION |
19 |
0.0011 |
| 716 |
AMENORRHOEA |
20 |
0.0011 |
| 717 |
THERAPEUTIC RESPONSE DECREASED |
69 |
0.0011 |
| 718 |
BLINDNESS UNILATERAL |
16 |
0.0011 |
| 719 |
OEDEMA PERIPHERAL |
138 |
0.0011 |
| 720 |
WEIGHT DECREASED |
316 |
0.0011 |
| 721 |
DIABETES MELLITUS INADEQUATE CONTROL |
20 |
0.0011 |
| 722 |
OSTEONECROSIS |
37 |
0.0011 |
| 723 |
APHASIA |
34 |
0.0011 |
| 724 |
SURGERY |
66 |
0.0011 |
| 725 |
ASTHENIA |
422 |
0.0011 |
| 726 |
CEREBRAL HAEMORRHAGE |
40 |
0.0011 |
| 727 |
HYPOTENSION |
224 |
0.0011 |
| 728 |
DYSPNOEA |
621 |
0.0011 |
| 729 |
INTRAOCULAR PRESSURE INCREASED |
14 |
0.0011 |
| 730 |
VENTRICULAR TACHYCARDIA |
18 |
0.0011 |
| 731 |
RENAL FAILURE ACUTE |
46 |
0.0011 |
| 732 |
RENAL INJURY |
32 |
0.0011 |
| 733 |
TREMOR |
178 |
0.0011 |
| 734 |
HEPATIC ENZYME INCREASED |
73 |
0.0011 |
| 735 |
ATRIAL FIBRILLATION |
104 |
0.0011 |
| 736 |
OBESITY |
17 |
0.0011 |
| 737 |
LIVER DISORDER |
47 |
0.0011 |
| 738 |
PERIPHERAL SWELLING |
163 |
0.0011 |
| 739 |
INFUSION RELATED REACTION |
70 |
0.0011 |
| 740 |
ABDOMINAL DISCOMFORT |
176 |
0.0010 |
| 741 |
URINARY RETENTION |
35 |
0.0010 |
| 742 |
UNRESPONSIVE TO STIMULI |
27 |
0.0010 |
| 743 |
HEADACHE |
650 |
0.0010 |
| 744 |
METASTASES TO BONE |
17 |
0.0010 |
| 745 |
RASH MACULO-PAPULAR |
23 |
0.0010 |
| 746 |
PREMATURE BABY |
31 |
0.0010 |
| 747 |
LIVER FUNCTION TEST INCREASED |
22 |
0.0010 |
| 748 |
NAUSEA |
803 |
0.0010 |
| 749 |
SKIN HAEMORRHAGE |
15 |
0.0010 |
| 750 |
PRODUCT PRESCRIBING ISSUE |
22 |
0.0010 |
| 751 |
MELAENA |
22 |
0.0010 |
| 752 |
MUSCULAR WEAKNESS |
113 |
0.0010 |
| 753 |
THERAPY CESSATION |
51 |
0.0010 |
| 754 |
HEPATIC FUNCTION ABNORMAL |
37 |
0.0010 |
| 755 |
SEASONAL ALLERGY |
14 |
0.0010 |
| 756 |
SINUSITIS |
101 |
0.0010 |
| 757 |
RASH ERYTHEMATOUS |
47 |
0.0010 |
| 758 |
BODY TEMPERATURE INCREASED |
20 |
0.0010 |
| 759 |
HIP ARTHROPLASTY |
15 |
0.0010 |
| 760 |
LYMPHOMA |
15 |
0.0010 |
| 761 |
RESPIRATORY DISORDER |
29 |
0.0010 |
| 762 |
HEPATIC STEATOSIS |
18 |
0.0010 |
| 763 |
DELUSION |
15 |
0.0010 |
| 764 |
INTESTINAL OBSTRUCTION |
36 |
0.0010 |
| 765 |
PRESCRIBED UNDERDOSE |
19 |
0.0010 |
| 766 |
PSORIATIC ARTHROPATHY |
38 |
0.0009 |
| 767 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
37 |
0.0009 |
| 768 |
HERNIA |
18 |
0.0009 |
| 769 |
NERVOUS SYSTEM DISORDER |
29 |
0.0009 |
| 770 |
JAUNDICE |
25 |
0.0009 |
| 771 |
EXPOSURE DURING PREGNANCY |
57 |
0.0009 |
| 772 |
RED BLOOD CELL COUNT DECREASED |
26 |
0.0009 |
| 773 |
SEIZURE |
105 |
0.0009 |
| 774 |
PANCREATITIS |
48 |
0.0009 |
| 775 |
ANGINA PECTORIS |
26 |
0.0009 |
| 776 |
FALL |
298 |
0.0009 |
| 777 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
23 |
0.0009 |
| 778 |
RASH PAPULAR |
20 |
0.0009 |
| 779 |
FATIGUE |
693 |
0.0009 |
| 780 |
TRANSIENT ISCHAEMIC ATTACK |
30 |
0.0009 |
| 781 |
INSOMNIA |
236 |
0.0009 |
| 782 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
22 |
0.0009 |
| 783 |
PULMONARY EMBOLISM |
84 |
0.0009 |
| 784 |
DISORIENTATION |
35 |
0.0009 |
| 785 |
PRODUCT PRESCRIBING ERROR |
21 |
0.0009 |
| 786 |
ALANINE AMINOTRANSFERASE INCREASED |
54 |
0.0009 |
| 787 |
PRODUCT USE ISSUE |
165 |
0.0009 |
| 788 |
SCAR |
15 |
0.0009 |
| 789 |
DYSPHAGIA |
83 |
0.0009 |
| 790 |
COLITIS ULCERATIVE |
39 |
0.0009 |
| 791 |
GAIT INABILITY |
29 |
0.0009 |
| 792 |
ARTHRALGIA |
360 |
0.0009 |
| 793 |
BLOOD POTASSIUM DECREASED |
26 |
0.0009 |
| 794 |
DEEP VEIN THROMBOSIS |
56 |
0.0009 |
| 795 |
THROMBOSIS |
69 |
0.0009 |
| 796 |
LOWER RESPIRATORY TRACT INFECTION |
39 |
0.0009 |
| 797 |
ABDOMINAL DISTENSION |
89 |
0.0009 |
| 798 |
LYMPHOCYTE COUNT DECREASED |
15 |
0.0008 |
| 799 |
LABORATORY TEST ABNORMAL |
25 |
0.0008 |
| 800 |
DEATH |
723 |
0.0008 |
| 801 |
INCREASED APPETITE |
16 |
0.0008 |
| 802 |
SWELLING |
78 |
0.0008 |
| 803 |
GLAUCOMA |
16 |
0.0008 |
| 804 |
BRADYCARDIA |
44 |
0.0008 |
| 805 |
JOINT SWELLING |
100 |
0.0008 |
| 806 |
CORONARY ARTERY DISEASE |
25 |
0.0008 |
| 807 |
FIBROMYALGIA |
20 |
0.0008 |
| 808 |
ACUTE MYOCARDIAL INFARCTION |
24 |
0.0008 |
| 809 |
HAEMORRHAGE |
85 |
0.0008 |
| 810 |
PSYCHOTIC DISORDER |
24 |
0.0008 |
| 811 |
LIMB INJURY |
22 |
0.0008 |
| 812 |
LIMB DISCOMFORT |
25 |
0.0008 |
| 813 |
ORTHOSTATIC HYPOTENSION |
14 |
0.0008 |
| 814 |
JOINT STIFFNESS |
21 |
0.0008 |
| 815 |
NEUROPATHY PERIPHERAL |
76 |
0.0008 |
| 816 |
ILLNESS |
82 |
0.0008 |
| 817 |
PRODUCT DOSE OMISSION ISSUE |
233 |
0.0008 |
| 818 |
MALAISE |
347 |
0.0008 |
| 819 |
RHINORRHOEA |
51 |
0.0008 |
| 820 |
SLEEP APNOEA SYNDROME |
15 |
0.0008 |
| 821 |
EPILEPSY |
24 |
0.0008 |
| 822 |
DYSPEPSIA |
77 |
0.0008 |
| 823 |
THROAT IRRITATION |
35 |
0.0008 |
| 824 |
PLATELET COUNT DECREASED |
82 |
0.0008 |
| 825 |
WEIGHT INCREASED |
171 |
0.0008 |
| 826 |
ANHEDONIA |
20 |
0.0008 |
| 827 |
HEART RATE INCREASED |
75 |
0.0008 |
| 828 |
WOUND |
21 |
0.0008 |
| 829 |
BRONCHITIS |
55 |
0.0007 |
| 830 |
ANAPHYLACTIC REACTION |
41 |
0.0007 |
| 831 |
WHEEZING |
44 |
0.0007 |
| 832 |
PAIN IN JAW |
21 |
0.0007 |
| 833 |
NEPHROLITHIASIS |
34 |
0.0007 |
| 834 |
WHITE BLOOD CELL COUNT DECREASED |
80 |
0.0007 |
| 835 |
OROPHARYNGEAL PAIN |
68 |
0.0007 |
| 836 |
DIZZINESS |
366 |
0.0007 |
| 837 |
PRURITUS |
279 |
0.0007 |
| 838 |
MOBILITY DECREASED |
52 |
0.0007 |
| 839 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
16 |
0.0007 |
| 840 |
ARTHRITIS |
56 |
0.0007 |
| 841 |
EPISTAXIS |
53 |
0.0007 |
| 842 |
HAEMATOCHEZIA |
39 |
0.0007 |
| 843 |
MUSCULOSKELETAL PAIN |
37 |
0.0007 |
| 844 |
BLOOD PRESSURE ABNORMAL |
14 |
0.0007 |
| 845 |
CHEST DISCOMFORT |
72 |
0.0007 |
| 846 |
LOSS OF CONSCIOUSNESS |
90 |
0.0007 |
| 847 |
IRRITABLE BOWEL SYNDROME |
15 |
0.0007 |
| 848 |
SWELLING FACE |
45 |
0.0007 |
| 849 |
DISCOMFORT |
42 |
0.0007 |
| 850 |
NASAL CONGESTION |
40 |
0.0007 |
| 851 |
RIB FRACTURE |
14 |
0.0007 |
| 852 |
EAR INFECTION |
18 |
0.0007 |
| 853 |
UNDERDOSE |
49 |
0.0007 |
| 854 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
120 |
0.0007 |
| 855 |
HYPERSOMNIA |
19 |
0.0007 |
| 856 |
STOMATITIS |
40 |
0.0007 |
| 857 |
NEOPLASM MALIGNANT |
44 |
0.0007 |
| 858 |
ASPARTATE AMINOTRANSFERASE INCREASED |
35 |
0.0007 |
| 859 |
CARDIAC DISORDER |
61 |
0.0007 |
| 860 |
RECTAL HAEMORRHAGE |
28 |
0.0007 |
| 861 |
DEAFNESS |
17 |
0.0006 |
| 862 |
BLOOD PRESSURE DECREASED |
43 |
0.0006 |
| 863 |
NASOPHARYNGITIS |
119 |
0.0006 |
| 864 |
BLOOD CHOLESTEROL INCREASED |
30 |
0.0006 |
| 865 |
DEPRESSED MOOD |
34 |
0.0006 |
| 866 |
PLASMA CELL MYELOMA |
25 |
0.0006 |
| 867 |
CHEST PAIN |
118 |
0.0006 |
| 868 |
ARTHROPATHY |
35 |
0.0006 |
| 869 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
28 |
0.0006 |
| 870 |
CHROMATURIA |
14 |
0.0006 |
| 871 |
FEMUR FRACTURE |
19 |
0.0006 |
| 872 |
ADVERSE DRUG REACTION |
55 |
0.0006 |
| 873 |
ANGIOEDEMA |
27 |
0.0006 |
| 874 |
SKIN DISCOLOURATION |
28 |
0.0006 |
| 875 |
LETHARGY |
35 |
0.0006 |
| 876 |
NECK PAIN |
34 |
0.0006 |
| 877 |
URINARY INCONTINENCE |
18 |
0.0006 |
| 878 |
COGNITIVE DISORDER |
28 |
0.0006 |
| 879 |
WHITE BLOOD CELL COUNT INCREASED |
23 |
0.0006 |
| 880 |
CEREBROVASCULAR ACCIDENT |
101 |
0.0006 |
| 881 |
ARRHYTHMIA |
28 |
0.0006 |
| 882 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
17 |
0.0006 |
| 883 |
OSTEOARTHRITIS |
25 |
0.0006 |
| 884 |
BLISTER |
33 |
0.0006 |
| 885 |
DYSARTHRIA |
22 |
0.0006 |
| 886 |
DYSPHONIA |
34 |
0.0006 |
| 887 |
POLLAKIURIA |
24 |
0.0006 |
| 888 |
CONFUSIONAL STATE |
93 |
0.0006 |
| 889 |
MUSCULOSKELETAL STIFFNESS |
50 |
0.0006 |
| 890 |
SKIN DISORDER |
19 |
0.0006 |
| 891 |
INTERNATIONAL NORMALISED RATIO INCREASED |
16 |
0.0006 |
| 892 |
GASTRIC DISORDER |
19 |
0.0006 |
| 893 |
RASH PRURITIC |
30 |
0.0006 |
| 894 |
SPEECH DISORDER |
29 |
0.0006 |
| 895 |
SLEEP DISORDER |
39 |
0.0006 |
| 896 |
CHOLELITHIASIS |
18 |
0.0005 |
| 897 |
ILL-DEFINED DISORDER |
33 |
0.0005 |
| 898 |
DRY MOUTH |
44 |
0.0005 |
| 899 |
CONTUSION |
52 |
0.0005 |
| 900 |
LUNG NEOPLASM MALIGNANT |
22 |
0.0005 |
| 901 |
THERAPEUTIC RESPONSE UNEXPECTED |
24 |
0.0005 |
| 902 |
ACCIDENTAL OVERDOSE |
19 |
0.0005 |
| 903 |
UNEVALUABLE EVENT |
39 |
0.0005 |
| 904 |
ALOPECIA |
101 |
0.0005 |
| 905 |
BACK PAIN |
119 |
0.0005 |
| 906 |
RASH |
223 |
0.0005 |
| 907 |
FLATULENCE |
29 |
0.0005 |
| 908 |
FOETAL EXPOSURE DURING PREGNANCY |
41 |
0.0005 |
| 909 |
PAIN IN EXTREMITY |
148 |
0.0005 |
| 910 |
DERMATITIS ATOPIC |
26 |
0.0005 |
| 911 |
GAIT DISTURBANCE |
94 |
0.0005 |
| 912 |
RHEUMATOID ARTHRITIS |
55 |
0.0005 |
| 913 |
VISUAL IMPAIRMENT |
60 |
0.0005 |
| 914 |
HEART RATE DECREASED |
17 |
0.0005 |
| 915 |
TYPE 2 DIABETES MELLITUS |
16 |
0.0005 |
| 916 |
MIGRAINE |
45 |
0.0005 |
| 917 |
DISTURBANCE IN ATTENTION |
25 |
0.0005 |
| 918 |
INFLUENZA LIKE ILLNESS |
38 |
0.0005 |
| 919 |
PALPITATIONS |
54 |
0.0005 |
| 920 |
MENTAL DISORDER |
20 |
0.0005 |
| 921 |
RASH MACULAR |
16 |
0.0005 |
| 922 |
FEELING HOT |
28 |
0.0005 |
| 923 |
HYPOAESTHESIA |
67 |
0.0004 |
| 924 |
SUICIDE ATTEMPT |
27 |
0.0004 |
| 925 |
DYSSTASIA |
13 |
0.0004 |
| 926 |
OCULAR HYPERAEMIA |
21 |
0.0004 |
| 927 |
BLOOD GLUCOSE INCREASED |
82 |
0.0004 |
| 928 |
HYPOGLYCAEMIA |
21 |
0.0004 |
| 929 |
RHABDOMYOLYSIS |
18 |
0.0004 |
| 930 |
VERTIGO |
26 |
0.0004 |
| 931 |
CONSTIPATION |
93 |
0.0004 |
| 932 |
PARAESTHESIA |
67 |
0.0004 |
| 933 |
NO ADVERSE EVENT |
77 |
0.0004 |
| 934 |
PAIN |
261 |
0.0004 |
| 935 |
DRY EYE |
21 |
0.0004 |
| 936 |
MUSCLE SPASMS |
77 |
0.0004 |
| 937 |
MYOCARDIAL INFARCTION |
73 |
0.0004 |
| 938 |
BURNING SENSATION |
29 |
0.0004 |
| 939 |
CARDIAC FAILURE CONGESTIVE |
33 |
0.0004 |
| 940 |
NEOPLASM PROGRESSION |
14 |
0.0004 |
| 941 |
ECZEMA |
21 |
0.0004 |
| 942 |
HYPERSENSITIVITY |
74 |
0.0004 |
| 943 |
ROAD TRAFFIC ACCIDENT |
16 |
0.0004 |
| 944 |
FEELING ABNORMAL |
91 |
0.0004 |
| 945 |
EYE SWELLING |
14 |
0.0004 |
| 946 |
URTICARIA |
62 |
0.0004 |
| 947 |
ADVERSE EVENT |
34 |
0.0004 |
| 948 |
AMNESIA |
24 |
0.0004 |
| 949 |
AGITATION |
27 |
0.0004 |
| 950 |
PRODUCT SUBSTITUTION ISSUE |
21 |
0.0004 |
| 951 |
DYSGEUSIA |
27 |
0.0004 |
| 952 |
ELECTROCARDIOGRAM QT PROLONGED |
13 |
0.0004 |
| 953 |
MEMORY IMPAIRMENT |
48 |
0.0003 |
| 954 |
BALANCE DISORDER |
30 |
0.0003 |
| 955 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
16 |
0.0003 |
| 956 |
ASTHMA |
38 |
0.0003 |
| 957 |
DEPRESSION |
76 |
0.0003 |
| 958 |
ERYTHEMA |
68 |
0.0003 |
| 959 |
ANXIETY |
94 |
0.0003 |
| 960 |
PSORIASIS |
43 |
0.0003 |
| 961 |
INJURY |
23 |
0.0003 |
| 962 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
17 |
0.0003 |
| 963 |
FLUSHING |
33 |
0.0003 |
| 964 |
HALLUCINATION |
23 |
0.0003 |
| 965 |
INJECTION SITE BRUISING |
24 |
0.0003 |
| 966 |
AGGRESSION |
15 |
0.0003 |
| 967 |
IRRITABILITY |
18 |
0.0003 |
| 968 |
CONVULSION |
17 |
0.0003 |
| 969 |
SKIN EXFOLIATION |
24 |
0.0003 |
| 970 |
EYE IRRITATION |
16 |
0.0003 |
| 971 |
ACNE |
21 |
0.0003 |
| 972 |
HOT FLUSH |
20 |
0.0003 |
| 973 |
INTENTIONAL OVERDOSE |
17 |
0.0003 |
| 974 |
HYPERHIDROSIS |
34 |
0.0003 |
| 975 |
DRY SKIN |
35 |
0.0003 |
| 976 |
EMOTIONAL DISTRESS |
31 |
0.0003 |
| 977 |
PRODUCT STORAGE ERROR |
21 |
0.0002 |
| 978 |
INJECTION SITE HAEMORRHAGE |
19 |
0.0002 |
| 979 |
DEVICE ISSUE |
21 |
0.0002 |
| 980 |
BONE PAIN |
13 |
0.0002 |
| 981 |
SUICIDAL IDEATION |
20 |
0.0002 |
| 982 |
INJECTION SITE REACTION |
15 |
0.0002 |
| 983 |
INCORRECT DOSE ADMINISTERED |
49 |
0.0002 |
| 984 |
INJECTION SITE SWELLING |
16 |
0.0002 |
| 985 |
OVERDOSE |
43 |
0.0002 |
| 986 |
PROSTATE CANCER |
16 |
0.0002 |
| 987 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
40 |
0.0002 |
| 988 |
MALIGNANT NEOPLASM PROGRESSION |
20 |
0.0002 |
| 989 |
INJECTION SITE PAIN |
53 |
0.0002 |
| 990 |
ACCIDENTAL EXPOSURE TO PRODUCT |
17 |
0.0002 |
| 991 |
BREAST CANCER |
14 |
0.0002 |
| 992 |
INJECTION SITE ERYTHEMA |
15 |
0.0001 |